Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,078.50    26.00 (2.47%)
Bid:
1,071.00
Ask:
1,072.00
Spread: 1.00 (0.093%)
Market Cap: £3.46b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Board Changes

15 Dec 2017 07:00

RNS Number : 4373Z
Persimmon PLC
15 December 2017
 

15 December 2017

 

Persimmon Plc

 

Board Changes

 

Persimmon Plc (the 'Company') announces that Nicholas Wrigley, Chairman, has informed the Board of his intention to resign. He will remain as Chairman to allow an orderly process while the Board seeks a successor. In addition Jonathan Davie, Senior Independent Director and Chairman of the Remuneration Committee, resigned from the Board on 14 December 2017.

 

The Company introduced a Long Term Incentive Plan in 2012 ("2012 LTIP"). The Board believes that the introduction of the 2012 LTIP has been a significant factor in the Company's outstanding performance over this period, led by a strong and talented Executive team. Nevertheless, Nicholas and Jonathan recognise that the 2012 LTIP could have included a cap. In recognition of this omission, they have therefore tendered their resignations.

 

The Company will now look to appoint a new Chairman and will report further in due course.

 

In addition, the Company announces that Nigel Mills has been appointed Senior Independent Director with effect from 14 December 2017 and will lead the process of appointing a new Chairman. Marion Sears has been appointed Chairman of the Remuneration Committee, also from 14 December 2017.

 

Since 2012, when the Capital Return Plan Strategy was launched and the 2012 LTIP was approved by shareholders, the Company has made substantial cash returns to shareholders at the same time as increasing the size of the business and delivering significant shareholder value. Since the strategy was launched, Persimmon has delivered an increase in the number of new homes supplied of over 65%, invested £2.9bn in new land, returned 485p per share (£1.5bn) in cash and increased the proposed capital return by 49% to 925p per share, c. £2.85 bn.

 

The Board would like to express its thanks to Nicholas Wrigley and Jonathan Davie for their valuable contribution to the success of the Company.

 

The Board looks forward to the scheduled full year trading update on 9 January 2018.

 

Further information, please contact:

 

Citigate Dewe Rogerson

 

Simon Rigby

Kevin Smith

Jos Bieneman

 

Tel: +44 (0)20 7638 9571

 

This announcement contains inside information

 

Classification: Inside information

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADDBDDCUBBGRS
Date   Source Headline
1st May 20257:00 amRNSAGM Trading Statement
25th Apr 202510:54 amRNSHolding(s) in Company
25th Apr 20259:24 amRNSHolding(s) in Company
11th Apr 20254:22 pmRNSHolding(s) in Company
3rd Apr 202510:15 amRNSHolding(s) in Company
2nd Apr 202512:22 pmRNSHolding(s) in Company
1st Apr 202512:03 pmRNSTotal Voting Rights
31st Mar 20253:14 pmRNSDirector/PDMR Shareholding
27th Mar 202510:08 amRNSHolding(s) in Company
25th Mar 20253:14 pmRNSDirector/PDMR Shareholding
24th Mar 20253:35 pmRNSAnnual Report 2024 and Notice of AGM 2025
24th Mar 20252:24 pmRNSHolding(s) in Company
11th Mar 20257:00 amRNSFull Year Results
6th Mar 20252:06 pmRNSHolding(s) in Company
3rd Mar 20253:35 pmRNSHolding(s) in Company
3rd Feb 202512:26 pmRNSTotal Voting Rights
14th Jan 20257:00 amRNS2024 Trading Statement
2nd Jan 20251:00 pmRNSTotal Voting Rights
10th Dec 20243:47 pmRNSDirectorate Change
2nd Dec 20242:11 pmRNSBlock listing Interim Review
2nd Dec 202412:00 pmRNSTotal Voting Rights
6th Nov 20247:00 amRNSQ3 Trading Statement
5th Nov 20241:31 pmRNSHolding(s) in Company
1st Nov 20243:59 pmRNSTotal Voting Rights
1st Oct 20241:19 pmRNSTotal Voting Rights
24th Sep 202412:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20241:44 pmRNSTotal Voting Rights
8th Aug 20247:00 amRNSHalf Year Results
1st Aug 20242:32 pmRNSTotal Voting Rights
23rd Jul 202410:28 amRNSDirectorate Change
1st Jul 20241:10 pmRNSTotal Voting Rights
19th Jun 20242:48 pmRNSDirector/PDMR Shareholding
3rd Jun 202412:33 pmRNSBlock listing Interim Review
3rd Jun 202411:08 amRNSTotal Voting Rights
23rd May 20247:00 amRNSConfirmation of CFO start date
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.